Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children

被引:10
作者
Wintergerst, U
Engelhorn, C
Kurowski, M
Hoffmann, F
Notheis, G
Belohradsky, BH
机构
[1] Univ Munich, Childrens Hosp, Dept Immunol & Infect Dis, D-80337 Munich, Germany
[2] Auguste Viktoria Hosp, HIV Lab, D-12157 Berlin, Germany
关键词
D O I
10.1097/00002030-200008180-00030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1866 / 1868
页数:3
相关论文
共 16 条
[1]   Indinavir concentrations and antiviral effect [J].
Acosta, EP ;
Henry, K ;
Baken, L ;
Page, LM ;
Fletcher, CV .
PHARMACOTHERAPY, 1999, 19 (06) :708-712
[2]   Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection [J].
Barry, M ;
Mulcahy, F ;
Merry, C ;
Gibbons, S ;
Back, D .
CLINICAL PHARMACOKINETICS, 1999, 36 (04) :289-304
[3]   Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity [J].
Falloon, J ;
Piscitelli, S ;
Vogel, S ;
Sadler, B ;
Mitsuya, H ;
Kavlick, MF ;
Yoshimura, K ;
Rogers, M ;
LaFon, S ;
Manion, DJ ;
Lane, HC ;
Masur, H .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) :313-318
[4]  
Ferry JJ, 1998, J ACQ IMMUN DEF SYND, V18, P252, DOI 10.1097/00042560-199807010-00009
[5]  
*GLAX WELLC, PROD INF AG
[6]   A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity [J].
Jackson, RC .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (06) :713-730
[7]   Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir [J].
Kempf, DJ ;
Marsh, KC ;
Kumar, G ;
Rodrigues, AD ;
Denissen, JF ;
McDonald, E ;
Kukulka, MJ ;
Hsu, A ;
Granneman, GR ;
Baroldi, PA ;
Sun, E ;
Pizzuti, D ;
Plattner, JJ ;
Norbeck, DW ;
Leonard, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :654-660
[8]  
Kurowski M, 1999, Eur J Med Res, V4, P101
[9]  
Kurowski M, 1999, 39 INT C ANT AG CHEM
[10]  
PIKETTY C, 1999, AIDS, V30, P71